Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients - PubMed (original) (raw)

Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients

Matteo Pirro et al. J Hypertens. 2007 Oct.

Abstract

Objective: Circulating endothelial progenitor cells (EPCs) differentiate into mature endothelial cells and regenerate the injured endothelium. The role of homeobox A9 (HOXA9) is critical for endothelial commitment during progenitor cell maturation, postnatal neovascularization and vascular repair. The objective of our study was to measure the expression of HOXA9 in CD34+ cells from hypertensive patients and to investigate its correlation with the number of circulating EPCs.

Methods: Thirty patients with newly diagnosed, never-treated essential hypertension and 30 age- and sex-matched normotensive controls were recruited for the study. Total RNA was extracted from peripheral CD34+ cells and quantitative real-time polymerase chain reaction for measurement of HOXA9 expression was performed. The number of CD34+/human kinase insert domain protein receptor + (KDR+) EPCs was measured and the Framingham risk estimated.

Results: Hypertensive patients had reduced HOXA9 expression compared to normotensive subjects (-26%, P < 0.001), and lower levels of peripheral CD34+/KDR+ EPCs (421 +/- 93 versus 582 +/- 101, P < 0.001). HOXA9 expression was inversely associated with systolic blood pressure (r = -0.54, P < 0.001) and the Framingham risk (r = -0.50, P < 0.001). A direct association was observed between the number of EPCs and HOXA9 expression (r = 0.50, P < 0.001), which was independent of blood pressure levels and Framingham risk. In a subgroup of 15 hypertensive patients, a 4-week treatment with ramipril was associated with a significant 15% increase in HOXA9 expression and 25% increase in EPC levels.

Conclusions: In hypertensive patients, downregulation of HOXA9 expression in peripheral CD34+ cells may have a role in the loss of circulating EPCs, thus potentially impairing postnatal neovascularization and vascular repair.

PubMed Disclaimer

Cited by

Molecular biology of atherosclerosis.
Mannarino E, Pirro M. Mannarino E, et al. Clin Cases Miner Bone Metab. 2008 Jan;5(1):57-62. Clin Cases Miner Bone Metab. 2008. PMID: 22460847 Free PMC article.
Decreased number of circulating endothelial progenitor cells in patients with Graves' hyperthyroidism.
De Ciuceis C, Pilu A, Cappelli C, Porteri E, Zani F, Santoro A, Gandossi E, Boari GE, Rizzardi N, Castellano M, Rizzoni D, Agabiti Rosei E. De Ciuceis C, et al. J Endocrinol Invest. 2011 May;34(5):335-9. doi: 10.1007/BF03347455. Epub 2010 Jun 28. J Endocrinol Invest. 2011. PMID: 20585201
PRMT5 Prevents Cardiomyocyte Hypertrophy via Symmetric Dimethylating HoxA9 and Repressing HoxA9 Expression.
Cai S, Liu R, Wang P, Li J, Xie T, Wang M, Cao Y, Li Z, Liu P. Cai S, et al. Front Pharmacol. 2020 Dec 10;11:600627. doi: 10.3389/fphar.2020.600627. eCollection 2020. Front Pharmacol. 2020. PMID: 33424610 Free PMC article.
Gene expression comparison reveals distinct basal expression of HOX members and differential TNF-induced response between brain- and spinal cord-derived microvascular endothelial cells.
Molino Y, Jabès F, Bonnet A, Gaudin N, Bernard A, Benech P, Khrestchatisky M. Molino Y, et al. J Neuroinflammation. 2016 Nov 10;13(1):290. doi: 10.1186/s12974-016-0749-6. J Neuroinflammation. 2016. PMID: 27832801 Free PMC article.
Genome-wide epigenetic and proteomic analysis reveals altered Notch signaling in EPC dysfunction.
Karcher JR, Hoffmann BR, Liu P, Liu Y, Liang M, Greene AS. Karcher JR, et al. Physiol Rep. 2015 Apr;3(4):e12358. doi: 10.14814/phy2.12358. Physiol Rep. 2015. PMID: 25921777 Free PMC article.

Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients - PubMed (original) (raw)